Correlation Between Nutanix and PharmChem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nutanix and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutanix and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nutanix and PharmChem, you can compare the effects of market volatilities on Nutanix and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutanix with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutanix and PharmChem.

Diversification Opportunities for Nutanix and PharmChem

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nutanix and PharmChem is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Nutanix and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and Nutanix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutanix are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of Nutanix i.e., Nutanix and PharmChem go up and down completely randomly.

Pair Corralation between Nutanix and PharmChem

Given the investment horizon of 90 days Nutanix is expected to under-perform the PharmChem. In addition to that, Nutanix is 7.65 times more volatile than PharmChem. It trades about -0.17 of its total potential returns per unit of risk. PharmChem is currently generating about -0.21 per unit of volatility. If you would invest  310.00  in PharmChem on September 24, 2024 and sell it today you would lose (5.00) from holding PharmChem or give up 1.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Nutanix  vs.  PharmChem

 Performance 
       Timeline  
Nutanix 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nutanix are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Nutanix may actually be approaching a critical reversion point that can send shares even higher in January 2025.
PharmChem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Nutanix and PharmChem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nutanix and PharmChem

The main advantage of trading using opposite Nutanix and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutanix position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.
The idea behind Nutanix and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities